Kenvue stock rallies off record low after Trump press conference on alleged Tylenol-autism link
Short excerpt below. Click through to read at the original source.
Kenvue stock rallied on Tuesday off a record low, after a White House press conference didn’t offer fresh evidence that could be used by plaintiffs to sue the maker of Tylenol for its alleged link to autism.